1-9 of 9
Paola E. Neri, MD
Close
Sort by
Journal Articles

Cereblon (CRBN) Splice Isoform Lacking Exon 10 Attenuates Lenalidomide-Mediated Degradation of Aiolos and Is Upregulated in Immunomodulatory Drugs (IMiDs) Resistant Myeloma (MM) Patients

Ranjan Maity, PhD, Paola E. Neri, MD PhD, Ines Tagoug, PhD, Li Ren, PhD, Jiri Slaby, MD, Victor H Jimenez-Zepeda, MD, Peter Duggan, MD, Justin Simms, Nizar J Bahlis, MD
Journal: Blood
Blood (2014) 124 (21): 639.
https://doi.org/10.1182/blood.V124.21.639.639
Published: 2014
Journal Articles

Bortezomib Containing Regimens Are Highly Effective for Systemic AL Amyloidosis: Experience from a Single Center

Victor H Jimenez Zepeda, MD, Peter Duggan, MD, Paola E. Neri, MD PhD, Nizar J Bahlis, MD
Journal: Blood
Blood (2014) 124 (21): 4743.
https://doi.org/10.1182/blood.V124.21.4743.4743
Published: 2014
Journal Articles

Bortezomib and Melphalan (Bor/MEL) Conditioning for Patients with Multiple Myeloma Undergoing Single Autologous Stem Cell Transplantation

Victor H Jimenez Zepeda, MD, Peter Duggan, MD, Paola E. Neri, MD PhD, Nizar J Bahlis, MD
Journal: Blood
Blood (2014) 124 (21): 1202.
https://doi.org/10.1182/blood.V124.21.1202.1202
Published: 2014
Journal Articles

Transcriptome Profiling of Lenalidomide Treated Myeloma Patients Identifies an Interferon Signature Gene Response and a Novel IRF4/MYC Independent Mechanism of Resistance

Paola E. Neri, MD PhD, Ines Tagoug, PhD, Li Ren, PhD, Ranjan Maity, PhD, Justin Simms, Peter Duggan, MD, Victor H Jimenez-Zepeda, MD, Jiri Slaby, MD, Howie Wu, Jackie Babich, Nizar J Bahlis, MD
Journal: Blood
Blood (2014) 124 (21): 170.
https://doi.org/10.1182/blood.V124.21.170.170
Published: 2014
Journal Articles

Pomalidomide and Dexamethasone Is an Effective Regimen for Advanced-Stage Relapsed/Refractory Multiple Myeloma: Experience of a Single Center

Victor H Jimenez Zepeda, MD, Peter Duggan, MD, Paola E. Neri, MD PhD, Nizar J Bahlis, MD
Journal: Blood
Blood (2014) 124 (21): 5747.
https://doi.org/10.1182/blood.V124.21.5747.5747
Published: 2014
Journal Articles

Cyclophosphamide, Bortezomib and Dexamethasone (CyBORD) Is a Feasible and Active Regimen for Non-Transplant Eligible Multiple Myeloma Patients

Victor H Jimenez Zepeda, MD, Peter Duggan, MD, Paola E. Neri, MD PhD, Nizar J Bahlis, MD
Journal: Blood
Blood (2014) 124 (21): 5751.
https://doi.org/10.1182/blood.V124.21.5751.5751
Published: 2014
Journal Articles

Lenalidomide Induced Degradation of Aiolos Disrupts RNA Polimerase I Activity and Ribosomal Biogenesis in Myeloma Cells

Ines Tagoug, PhD, Jiri Slaby, MD, Paola E. Neri, MD PhD, Justin Simms, Jackie Babich, Ranjan Maity, PhD, Li Ren, PhD, Howie Wu, Nizar J Bahlis, MD
Journal: Blood
Blood (2014) 124 (21): 3422.
https://doi.org/10.1182/blood.V124.21.3422.3422
Published: 2014
Journal Articles

IMiDs® Immunomodulatory Agents Regulate Interferon-Stimulated Genes through Cereblon-Mediated Aiolos Destruction in Multiple Myeloma (MM) Cells: Identification of a Novel Mechanism of Action and Pathway for Resistance

Courtney G. Havens, PhD, Chad Bjorklund, PhD, Jian Kang, BS, Maria Ortiz, PhD, Celia Fontanillo, PhD, Michael Amatangelo, PhD, Ling Lu, BS, Paola E. Neri, MD PhD, Antonia Lopez-Girona, PhD, Nizar J. Bahlis, MD, Anjan Thakurta, PhD, Mathew Trotter, MD, Anita K. Gandhi, PhD, Anke Klippel, PhD, Rajesh Chopra, MD PhD
Journal: Blood
Blood (2014) 124 (21): 3432.
https://doi.org/10.1182/blood.V124.21.3432.3432
Published: 2014
Journal Articles

Identification of Novel Antigens with Induced Immune Response in MGUS.

Simona Blotta, MD, Hiroshi Yasui, MD, Pierfrancesco Tassone, MD, Roberto Bellucci, PhD, Yu-Tzu Tai, PhD, Rao Prabhala, PhD, Masood A. Shammas, PhD, Pierosandro Tagliaferri, MD, Klaus Podar, MD, PhD, Paola E. Neri, MD, Mariateresa Fulciniti, PhD, Vidit Munshi, Dharminder Chauhan, PhD, Teru Hideshima, MD, PhD, Salvatore Venuta, MD, PhD, Jerome Ritz, MD, Kenneth C. Anderson, MD, Nikhil C. Munshi, MD
Journal: Blood
Blood (2006) 108 (11): 655.
https://doi.org/10.1182/blood.V108.11.655.655
Published: 2006